Compare places

Two or three clusters, read side by side across sectors, research, companies, capital, infrastructure, government designations and UKIZ relevance. There is no score and no ranking: British clusters are different from one another, not better or worse than one another.

Choose up to three clusters

Side by side

Dimension	CambridgeEast of England	ManchesterNorth West	Leeds & West YorkshireYorkshire and the Humber
Sectors	Life Sciences, Semiconductors, Engineering Biology, Artificial Intelligence Supporting: Quantum Technologies, Advanced Materials, AgriTech & FoodTech, Digital Technologies	Advanced Materials, Life Sciences, Digital Technologies, Creative Industries Supporting: Artificial Intelligence, Advanced Manufacturing, Financial Technology, Engineering Biology	Life Sciences, Digital Technologies, Financial Technology Supporting: Artificial Intelligence, Advanced Manufacturing, Creative Industries
Research	University of Cambridge Wellcome Sanger Institute MRC Laboratory of Molecular Biology	The University of Manchester Manchester Metropolitan University National Graphene Institute Greater Manchester health innovation partnership	University of Leeds
Companies	Cambridge semiconductor and processor IP cluster	Not recorded on the map.	Leeds health data and digital health cluster
Infrastructure	Babraham Research Campus Cambridge Science Park University and institute laboratories, genomics and biomedical campus facilities, and semiconductor design capability.	MediaCity Advanced manufacturing Catapult capability, North West National materials and graphene facilities, teaching hospitals and clinical research capability, and a major broadcast production estate.	Not recorded on the map. Health data infrastructure, teaching hospitals and university research facilities.
Capital	Specialist deep tech and life science funds, university-linked funds, and corporate partners; strong at seed, thinner at growth stage relative to demand.	A growing regional investor base and northern funds, with growth rounds usually led from London.	Financial services depth locally, but early-stage health technology capital remains limited.
Government programmes	No place-based designation recorded.	No place-based designation recorded.	No place-based designation recorded.
What exists	Extreme research density for its size: life sciences and genomics, semiconductor and processor IP, engineering biology and AI, with a mature spin-out culture and specialist investors who understand long timelines.	Advanced materials research including graphene and 2D materials, a large health innovation base built on hospitals and universities, a substantial digital and cyber economy, and the biggest broadcast and creative cluster outside London.	National health data organisations, medical technology, a large financial and professional services base and a research university with data and materials strength.
What's missing · UKIZ interpretation	Ownership retention. Discovery and early company formation work; the Series B onward stage frequently transfers ownership overseas. Laboratory and scale-up space, power and housing also constrain growth.	The step from materials discovery to volume production, and a growth capital base proportionate to the research output. Health data at population scale is under-used by industry.	A clear route for companies to work with health data at scale, and clinical adoption pathways that move faster than pilot projects.
What could connect · UKIZ interpretation	Cambridge discovery connected to UK manufacturing and biomanufacturing capacity, and to later-stage domestic capital, so that value created here is realised here rather than acquired out of the country.	Materials research connected to Sheffield and Midlands manufacturing, and health innovation connected to Leeds health data capability — a corridor rather than three separate cities.	Leeds health data capability connected to Manchester clinical research and to medical technology manufacturing, giving companies discovery, evidence and production in one region.
UKIZ relevance	Cambridge produces intellectual property at a rate few places match, and loses ownership of too much of it at Series B. The proposed Oxford–Cambridge zone concentrates on commercialisation and retention rather than on more discovery.	Manchester has scale in four different economies that rarely commission from each other. The proposed zone concentrates on connecting health, materials, digital and creative capability around shared missions.	Health data at population scale is a national asset. The proposed Manchester mission and Leeds capability are complementary rather than competing.
Last verified	15 August 2026	15 August 2026	15 August 2026

Proposed by UKIZ · not a government designation

Back to the map →Methodology →